Institutional Review Board

The Institutional Review Board (IRB) is a group that is tasked with safeguarding the rights and welfare of people participating in research. These participants’ rights, which include voluntarism and informed consent, are enumerated in various federal regulations and historical guidelines. The IRB must not only protect human subjects, but it must evaluate new and ongoing research with respect to science, law, ethics, and community attitudes. McLeod Health has a local IRB that reviews many research studies, but external IRB entities are also utilized when appropriate.

To learn more about IRBs and how they help protect people who participate in research, check out this video from the U.S. Department of Health and Human Services.


Diversity of IRB membership is important in order to sufficiently evaluate all types of human subject research. Membership cannot include just men or just women, nor can the Board be made up of members from only one profession. Additionally, there must be at least one member from a non-scientific area and one member who is not affiliated with the institution. Our Institutional Review Board consists of approximately 18 individuals who support McLeod’s dedication to research and patient protection. Click here for a list of our members.

Clinical Trials

McLeod Health participates in a variety of local and national research trials. Click here to learn more.

IRB Meeting Dates for 2022

Meetings begin at 1:30 p.m. in the Cancer Center Conference Room (1st floor of the McLeod Cancer Center) unless otherwise communicated to IRB members and guests.



Please note the submission dates. All documentation must be submitted electronically to Toshia Jones, IRB Coordinator, by that date in order to be reviewed at the subsequent meeting.

If you have any questions, please feel free to call (843) 777-2013 or e-mail